SARS-CoV-2 Vaccine Response in Patients With Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis

Overview

Journal Kidney Int Rep

Publisher Elsevier

Specialty Nephrology

Date 2021 Dec 20

PMID 34926870

Citations 5

Authors

Lauren Floyd

Mohamed E Elsayed

Tobias Seibt

Anke von Bergwelt-Baildon

Philip Seo

Brendan Antiochos

Sam Kant

Adam Morris

Ajay Dhaygude

Ulf Schonermarck

Duvuru Geetha

Affiliations

Soon will be listed here.

Citing Articles

Effect of Immunosuppression on the Immune Response to SARS-CoV-2 Infection and Vaccination.

Leacy E, Teh J, ORourke A, Brady G, Gargan S, Conlon N Int J Mol Sci. 2024; 25(10).

PMID: 38791279 PMC: 11120762. DOI: 10.3390/ijms25105239.

Antibody response to four doses of SARS-CoV-2 vaccine in rare autoimmune rheumatic diseases: an observational study.

Gumber L, Jackson H, Gomez N, Hopkins G, Tucis D, Chakravorty M Rheumatol Adv Pract. 2024; 7(3):rkad097.

PMID: 38515961 PMC: 10956718. DOI: 10.1093/rap/rkad097.

Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial.

Geetha D, Dua A, Yue H, Springer J, Salvarani C, Jayne D Ann Rheum Dis. 2023; 83(2):223-232.

PMID: 37979959 PMC: 10850685. DOI: 10.1136/ard-2023-224816.

Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 2019.

Sattui S, Wallace Z Rheum Dis Clin North Am. 2023; 49(3):695-711.

PMID: 37331741 PMC: 10011035. DOI: 10.1016/j.rdc.2023.03.007.

Overview of infections as an etiologic factor and complication in patients with vasculitides.

Theofilis P, Vordoni A, Koukoulaki M, Vlachopanos G, Kalaitzidis R Rheumatol Int. 2022; 42(5):759-770.

PMID: 35165771 PMC: 8853270. DOI: 10.1007/s00296-022-05100-9.

References

Spiera R, Jinich S, Jannat-Khah D . Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS- CoV-2 vaccination in patients with rheumatic diseases. Ann Rheum Dis. 2021; 80(10):1357-1359. DOI: 10.1136/annrheumdis-2021-220604. View

Turner-Stokes T, Sandhu E, Pepper R, Stolagiewicz N, Ashley C, Dinneen D . Induction treatment of ANCA-associated vasculitis with a single dose of rituximab. Rheumatology (Oxford). 2014; 53(8):1395-403. DOI: 10.1093/rheumatology/ket489. View

Prendecki M, Clarke C, Edwards H, McIntyre S, Mortimer P, Gleeson S . Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression. Ann Rheum Dis. 2021; 80(10):1322-1329. PMC: 8350975. DOI: 10.1136/annrheumdis-2021-220626. View

Connolly C, Koenig D, Ravi S, Azar A, Kant S, Dalal M . Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response" by Bonelli . Ann Rheum Dis. 2021; 80(10):e164. DOI: 10.1136/annrheumdis-2021-220972. View

Kant S, Kronbichler A, Salas A, Bruchfeld A, Geetha D . Timing of COVID-19 Vaccine in the Setting of Anti-CD20 Therapy: A Primer for Nephrologists. Kidney Int Rep. 2021; 6(5):1197-1199. PMC: 8012272. DOI: 10.1016/j.ekir.2021.03.876. View